Healios KK Ord Shs HLOSF

Healthcare Biotechnology

HEALIOS K.K. is a Japan-based company mainly engaged in research and development of pharmaceutical products. The Company has compound pharmaceutical products line and induced pluripotent stem cell (iPSC) regenerative medicine product line. The compound pharmaceutical product line contains HLM0021, HLM0022 and HLM0023. The products are ophthalmological surgery adjuvants, mainly contain brilliant blue G-250 (BBG250) which help capsule temporarily safely stained to protect the inner limiting membranes and lens during surgery of vitreous and cataract. The iPSC regenerative medicine product line contains HLCR011 and HLCR012. The products are in the preclinical testing and preparation for trial in Japan, which are candidate of regenerative medicine products. The products are iPS cell derived retinal pigment epithelium (RPE) cell suspension and sheet developed in Japan, United States and Europe.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Joe takes HLO to 30s in weeks

<< Previous

Bullboard Posts

Next >>

Comment by ama21968on Jan 30, 2011 10:33pm

263 Views

Post# 18048293

RE: Joe takes HLO to 30s in weeks

That will be super!! 2 bits you are so funny!!

I will double my position if Halo drops to 30s then Triple in 20s!

In the past 3 days. I believe Joe has dumped approx 4.5 Million shares of 1.46 Million shares by Jan 11, 2011. Only 1 Million shares left ( only 3.5% O/S )

Man!! I don't believe Pinetree, HBM, RBC Lynda and whoever bought in 50 cents financing are trapped!!

At least 9 Million shares (32% O/S) are trapped by 3.5% O/S holder? What a joke!!

GLTA

<< Previous

Bullboard Posts

Next >>

Silvercorp to expand into Ecuador with C$200M Adventus acquisition